Skip to content

Venture

LOGO 9-01

Technologies

Pharmaceutical Drug

Therapeutic

Indication

Fibrosis

Oncology

Additional Information

Women Founded

Synthis is developing a novel immuno-oncology (IO) therapeutic that reserves immune suppression in metastatic melanoma patients who have failed immune checkpoint blockade.

 

Team:
Dori T. Karyat, Ph.D., Founder